Physician profile
Sandra Gallo
NPI 1184753717
$4,308.13
in general payments reported to CMS, 2019-2025
22 companies · $941 in 2025
The $941 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,038 · 2022: $1,731 · 2023: $150 · 2024: $449 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,020.83 | 2021-2022 | |
| Boston Scientific Corporation | $509.48 | 2021-2025 | Entrada, General - Therapies, Intracept |
| Globus Medical, INC. | $458.73 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $199.71 | 2021-2025 | Relistor |
| Abbvie INC. | $196.57 | 2021-2025 | |
| Si-Bone, INC. | $174.34 | 2024 | |
| Mml US, INC. | $128.28 | 2025 | Reactiv8 |
| Spr Therapeutics, INC | $86.74 | 2024-2025 | Sprint Pns System |
| Stryker Corporation | $67.82 | 2021 | |
| Intuitive Surgical, INC. | $60.29 | 2022 | |
| Collegium Pharmaceutical, INC. | $60.23 | 2022-2024 | Xtampza |
| Saluda Medical Americas, INC. | $54.57 | 2024 | Evoke |
| Scilex Pharmaceuticals INC. | $54.15 | 2021-2024 | |
| Biodelivery Sciences International, INC. | $46.25 | 2021 | |
| Alfasigma USA, INC. | $37.29 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $34.54 | 2025 | |
| Amgen INC. | $27.47 | 2022 | |
| Bioventus LLC | $24.95 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $23.99 | 2021 | |
| Pfizer INC. | $15.85 | 2024 | |
| Inspire Medical Systems, INC. | $13.38 | 2024 | Inspire |
| Electronic Waveform Lab, INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Gallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.